PINK1/Park2-Mediated Mitophagy Relieve Non-Alcoholic Fatty Liver Disease

Overview

Journal Physiol Res

Specialty Physiology

Date 2024 May 6

PMID 38710055

Authors

H He

Y Tang

L Zhuang

Y Zheng

X Huang

Affiliations

Soon will be listed here.

Abstract

Up to now, there's a limited number of studies on the relationship between PINK1/Park2 pathway and mitophagy in NAFLD. To investigate the effect of Park2-mediated mitophagy on non-alcoholic fatty liver disease (NAFLD). Oleic acid was used for the establishment of NAFLD model. Oil red-dyed lipid drops and mitochondrial alternations were observed by transmission electron microscopy. Enzymatic kit was used to test lipid content. The levels of IL-8 and TNF-alpha were determined by ELISA. Lenti-Park2 and Park2-siRNA were designed to upregulate and downregulate Park2 expression, respectively. The changing expression of PINK and Park2 was detected by RT-qPCR and Western blot. Immunofluorescence staining was applied to measure the amount of LC3. Successful NAFLD modeling was featured by enhanced lipid accumulation, as well as the elevated total cholesterol (TC), triglyceride (TG), TNF-alpha and IL-8 levels. Mitochondria in NAFLD model were morphologically and functionally damaged. Park2 expression was upregulated by lenti-Park2 and downregulated through Park2-siRNA. The PINK1 expression showed the same trend as Park2 expression. Immunofluorescence staining demonstrated that the when Park2 was overexpressed, more LC3 protein on mitochondrial autophagosome membrane was detected, whereas Park2 knockdown impeded LC3' locating on the membrane. The transmission electron microscopy image exhibited that the extent of damage to the mitochondrial in NAFLD model was revered by enhanced Park2 expression but further exacerbated by reduced Park2 expression. Park2-mediated mitophagy could relive NAFLD and may be a novel therapeutic target for NAFLD treatment. Keywords: Non-alcoholic Fatty Liver Disease (NAFLD), Mitophagy, PINK1/Park2, Park2, PINK1.

References

Alshehri A, El-Kott A, El-Kenawy A, Khalifa H, AlRamlawy A . Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis. Sci Total Environ. 2021; 784:147182. DOI: 10.1016/j.scitotenv.2021.147182. View

Zhang J, Xie H, Yao J, Jin W, Pan H, Pan Z . TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination. Hum Cell. 2022; 36(1):209-222. DOI: 10.1007/s13577-022-00820-3. View

Vyas S, Zaganjor E, Haigis M . Mitochondria and Cancer. Cell. 2016; 166(3):555-566. PMC: 5036969. DOI: 10.1016/j.cell.2016.07.002. View

Wen Y, Xing X, Harris J, Zaytseva Y, Mitov M, Napier D . Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis. 2017; 8(2):e2593. PMC: 5386470. DOI: 10.1038/cddis.2017.21. View

Chacko K, Reinus J . Extrahepatic Complications of Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2016; 20(2):387-401. DOI: 10.1016/j.cld.2015.10.004. View

Shen S, Wang J, Lin L . Downregulation of long non-coding RNA AIRN promotes mitophagy in alcoholic fatty hepatocytes by promoting ubiquitination of mTOR. Physiol Res. 2021; 70(2):245-253. PMC: 8820571. DOI: 10.33549/physiolres.934549. View

Nassir F, Ibdah J . Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci. 2014; 15(5):8713-42. PMC: 4057755. DOI: 10.3390/ijms15058713. View

Mir H, Stepanova M, Afendy H, Cable R, Younossi Z . Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study. J Clin Exp Hepatol. 2015; 3(3):181-5. PMC: 3940103. DOI: 10.1016/j.jceh.2013.06.004. View

Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman P . Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease. Front Immunol. 2022; 13:880298. PMC: 9122097. DOI: 10.3389/fimmu.2022.880298. View

10.

Yu X, Hao M, Liu Y, Ma X, Lin W, Xu Q . Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. Eur J Pharmacol. 2019; 864:172715. DOI: 10.1016/j.ejphar.2019.172715. View

11.

Bingol B, Sheng M . Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond. Free Radic Biol Med. 2016; 100:210-222. DOI: 10.1016/j.freeradbiomed.2016.04.015. View

12.

Li S, Lin Q, Shao X, Zhu X, Wu J, Wu B . Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction. Free Radic Biol Med. 2019; 152:632-649. DOI: 10.1016/j.freeradbiomed.2019.12.005. View

13.

Kane L, Lazarou M, Fogel A, Li Y, Yamano K, Sarraf S . PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol. 2014; 205(2):143-53. PMC: 4003245. DOI: 10.1083/jcb.201402104. View

14.

Sliter D, Martinez J, Hao L, Chen X, Sun N, Fischer T . Parkin and PINK1 mitigate STING-induced inflammation. Nature. 2018; 561(7722):258-262. PMC: 7362342. DOI: 10.1038/s41586-018-0448-9. View

15.

Bueno M, Lai Y, Romero Y, Brands J, St Croix C, Kamga C . PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J Clin Invest. 2015; 125(2):521-38. PMC: 4319413. DOI: 10.1172/JCI74942. View

16.

Bakula D, Scheibye-Knudsen M . MitophAging: Mitophagy in Aging and Disease. Front Cell Dev Biol. 2020; 8:239. PMC: 7179682. DOI: 10.3389/fcell.2020.00239. View

17.

Zhang T, Qin H, Wang T, Li H, Li H, Xia S . Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review. Springerplus. 2015; 4:776. PMC: 4678134. DOI: 10.1186/s40064-015-1542-1. View

18.

Younossi Z, Anstee Q, Marietti M, Hardy T, Henry L, Eslam M . Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2017; 15(1):11-20. DOI: 10.1038/nrgastro.2017.109. View

19.

Kang D, Hamasaki N . Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem. 2005; 12(4):429-41. DOI: 10.2174/0929867053363081. View

20.

Saigo Y, Sasase T, Tohma M, Uno K, Shinozaki Y, Maekawa T . High-cholesterol diet in combination with hydroxypropyl-beta-cyclodextrin induces NASH-like disorders in the liver of rats. Physiol Res. 2023; 72(3):371-382. PMC: 10668992. DOI: 10.33549/physiolres.934981. View